Mark Roffman

Head-Clinical Development at Gel Med Sciences, Inc.

Mark Roffman

Mark Roffman

Head-Clinical Development at Gel Med Sciences, Inc.

Overview
Career Highlights

Clinsearch, Inc.

RelSci Relationships

536

Contact Data
Trying to get in touch with Mark Roffman? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Mark Roffman likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Vice Chairman at Jefferson Health System, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Gel Med Sciences, Inc.

Relationship likelihood: Strong

Executive Vice President, Head-Research & Strategic Development at Gel Med Sciences, Inc.

Relationship likelihood: Strong

Former Chairman & Acting Chief Executive Officer at North Park University

Relationship likelihood: Average

Professional at Gel Med Sciences, Inc.

Relationship likelihood: Average

Partner at Novitas Capital III LP

Relationship likelihood: Average

President at The Pennsylvania State University

Relationship likelihood: Average

Head, Information Technology at The Pennsylvania State University

Relationship likelihood: Average

Head, Serials & Acquisitions Services at The Pennsylvania State University

Relationship likelihood: Average

Associate Vice Provost, Information Technology at The Pennsylvania State University

Relationship likelihood: Average

Paths to Mark Roffman
Potential Connections via
Relationship Science
You
Mark Roffman
Head-Clinical Development at Gel Med Sciences, Inc.
Career History
President & Chief Executive Officer
Current

Clinsearch, Inc. is an American private company located in Kenilworth, NJ. The firm provides clinical research services. Mark Roffman is currently the CEO of the company. Clinsearch, Inc. was acquired by Comprehensive NeuroScience, Inc. on 29 Jul 02.

Head-Clinical Development
Current

Gel Med Sciences, Inc. engages in the development of animal and human healthcare products. It offers ovugel that utilizes the company's gel drug delivery system to improve the timing of artificial inseminations in pig herds. The company was founded by Joseph S Duffey in 1999 and is headquartered in Wayne, PA.

Vice President-Clinical & Regulatory Affairs
Prior

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mark Roffman. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mark Roffman's profile does not indicate a business or promotional relationship of any kind between RelSci and Mark Roffman.